Physiological inhibitors of blood coagulation and prothrombin fragment F 1+2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy

Acta Diabetologica

Volumn 33, Issue 3, 1996, Pages 241-245

  Mormile, A ^b   Veglio, M ^a,c   Gruden, G ^a   Girotto, M ^b   Rossetto, P ^b   D'Este, P ^b   Cavallo Perin, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b USSL 40   (Italy)

^c NONE   (Italy)

Author keywords

Coagulation inhibitors; Nephropathy; Non insulin dependent diabetes mellitus

Indexed keywords

ALBUMIN; ANTITHROMBIN III; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBOMODULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029857533     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02048551     Document Type: Article

References (30)

1. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarret RJ, Keen H, A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates. Diabetologia 33:538-541, 1990
2. Fuller JH, Keen H, Jarret RJ, Omer T, Meade T, Chakrabarti R, North WRS, Stirling Y, Haemostatic variables associated with diabetes and its complications. Dr Med J 2:964-966, 1979
3. Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T, Microalbuminuria: implication for micro- and macrovascular disease. Diabetes Care 9: 1181-1191, 1992
4. Kwaan HC, Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes. Diabetes 35:617-619, 1986
5. Schmitz A, Ingerslev J, Haemostatic measures in type 2 diabetic patients with inicroalbuminuria. Diabetic Med 7:521-525, 1990
6. Knöbl P, Schernlhaner G, Schnack C, Pielschmann P, Gnesmacher A, Prager R, Müller M, Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050, 1993
7. Veglio M, Gruden G, Mormile A, Girotto M, Rossetto P, D'Este P, Cavallo-Perin P, Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria. Acta Diabetol 32:106-109, 1995
8. Teitel JM, Bauer KA, Lau HK, Rosenberg RD, Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombm complex. Blood 59:1086, 1982
9. Martinoli JR, Stocker K, Fast functional protein C assay using Protac. a novel protein C activator. Thromb Res 43:253-264, 1986
10. Wolf M, Boyer-Neuman C, Marlinoli JR, Amiral J, Meyer D, Larrieu MJ, A new functional assay for human protein S using activated factor Vas substrate. Thromb Haemost 62:1144-1145, 1989
11. Claus A, Measurement of fibnnogen. Acta Haematol 17:237-242, 1957
12. Baker IA, Eastham R, Elwood PC, Ethrington M, O'Brien JR, Sweetnam PM. Haemostatic factors associated with ischemic heart disease in men aged 45 to 64 years. Br Heart J 47:490-494, 1982
13. Yarnell JWG, Sweetnam PM, Elwood PC, Eastham R, Gilmour RA, O'Brien JR, Ethrington MD, Haemostasis factors and ischaemic heart disease: the Caerphilly study. Br Heart J 53: 483-487, 1985
14. Iwashima Y, Sato T, Watanabe K, Ooshima E, Hiraislii S, Ishii H, Kazama M, Makino I, Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39:983-988, 1990
15. Vukovich TC, Schernthaner G, Decreased protein C levels in patients with insulin-dependent type I diabetes mellitus. Diabetes 35:617-619, 1986
16. Viganò S, Mannucci PM, D'Angelo A, Gelfi C, Gensini GF, Rostagno C, Nen Serneri GG, Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes. Thromb Haemost 52:263-266, 1984
17. Ceriello A, Quatraro A, Dello Russo P, Marchi E, Barbanti M, Milani MR, Giughano D, Protein C deficiency in insulin dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost 64:104-107, 1990
18. Biondi G, Sorano GG, Conti M, Mameh G, Cirillo R, Marongiu F, The behaviour of protein C is still an open question. Thromb Haemost 66:267, 1991
19. Schernthaner G, Vukovich T, Knobl P, Hay U, Muller MM, The effect of near normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant protein C and S in insulin-dependent diabetic patients. Br J Haematol 73:356-359, 1989
20. Takahashi H, Tatewaki W, Wada K, Shibata A, Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy. Clin Chim Acta 182:195-208, 1989
21. Garcia Frade LJ, De la Calle H, Torrado MC, Lara JL, Cuaellar L, Garcia Avello A, Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes melhtus. Thromb Res 59:51-59, 1990
22. Carmassi F, Morale M, Puccetti R, De Negri F, Monzani F, Navalesi R, Mariani G, Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 67: 643-654, 1992
23. Brownlee M, Cerami A, Vlassara H, Advanced products of non enzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4:437-451, 1988
24. Patrassi GM, Picchienna R, Vettor R, Cappellatto G, Coccarieli A, Girolami A, Antithrombin III activity and concentration in diabetes mellitus. Thromb Haemost 54:415-517, 1985
25. Ceriello A, Dello Russo P, Zuccotti C, Florio A, Nazzaro S, Pietrantuono C, Rosato GB, Decreased antithrombin III activity in diabetes may be due to non enzymatic glycosylation. A preliminary report. Thromb Haemost 50:633-634, 1983
26. Ceriello A, Giuliano D, Quatraro A, Stante A, Consoli G, Dello Russo P, D'Onofrio F, Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for liable non-enzymatic glycation. Diabetes Metab 13:16-19, 1987
27. Ceriello A, Giuliano D, Quatraro A, Stante A, Consoli G, Dello Russo P, D'Onofrio F, Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 36:320-323, 1987
28. Decken T, Feldt-Rasmussen B, Borch-Johenscn K, Jensen T, Kofoed-Enevoidsen A, Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetoloeia 32:219-226, 1989
29. Gruden G, Bazzan M, Stella S, Pagano G, Pileri A, Cavallo-Perin P, Microalbuminuria in insulin-dependent diabetes is associated with high levels of prothrombin fragment 1+2. Thromb Res 72:541-546, 1993
30. Gruden G, Cavallo-Perin P, Romagnoli R, Olivetti C, Frezet D, Pagano G, Prothrombin fragment F 1+2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients. Diabetic Med 11:485-488, 1994